Active surveillance (AS) has been proposed as a possible management option for patients with recurrent low-grade non-muscle-invasive bladder cancer. Recent studies suggest that AS is a safe and effective management strategy.
Nevertheless, a consensus statement is needed to standardize inclusion criteria and follow-up schedules.
European urology focus. 2023 Apr 12 [Epub ahead of print]
Roberto Contieri, Massimo Lazzeri, Rodolfo Hurle
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy; Department of Urology, IRCCS Humanitas Research Hospital, Rozzano, Italy. Electronic address: ., Department of Urology, IRCCS Humanitas Research Hospital, Rozzano, Italy.
PubMed http://www.ncbi.nlm.nih.gov/pubmed/37059619